A 68-year-old man presents with progressive shortness of breath, orthopnoea and bilateral ankle oedema. Echocardiogram shows an ejection fraction of 30% with dilated ventricles. He is currently on ramipril and furosemide. According to CCS heart failure guidelines, which additional class of medication should be introduced next to improve survival, assuming no contraindications?